Gene · 274
Papers2,900
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 2,900
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Bin1 targeted immunotherapy alters the status of the enteric neurons and the microbiome during ulcerative colitis treatment. | PLoS One | 2022 | 36322599 | PubTator, text mining | PubMed |
| The targets of aspirin in bladder cancer: bioinformatics analysis. | BMC Urol | 2022 | 36316768 | PubTator, text mining | PubMed |
| Epigenetics of neural differentiation: Spotlight on enhancers. | Front Cell Dev Biol | 2022 | 36313573 | PubTator, text mining | PubMed |
| Mining of transcriptome identifies CD109 and LRP12 as possible biomarkers and deregulation mechanism of T cell receptor pathway in Acute Myeloid Leukemia. | Heliyon | 2022 | 36299526 | PubTator, text mining | PubMed |
| Detecting Reconnaissance and Discovery Tactics from the MITRE ATT&CK Framework in Zeek Conn Logs Using Spark's Machine Learning in the Big Data Framework. | Sensors (Basel) | 2022 | 36298351 | PubTator, text mining | PubMed |
| Epigenetic Changes in Prion and Prion-like Neurodegenerative Diseases: Recent Advances, Potential as Biomarkers, and Future Perspectives. | Int J Mol Sci | 2022 | 36293477 | PubTator, text mining | PubMed |
| Epigenetic Changes and Chromatin Reorganization in Brain Function: Lessons from Fear Memory Ensemble and Alzheimer's Disease. | Int J Mol Sci | 2022 | 36292933 | PubTator, text mining | PubMed |
| Amyloidogenesis and Neurotrophic Dysfunction in Alzheimer's Disease: Do They have a Common Regulating Pathway? | Cells | 2022 | 36291068 | PubTator, text mining | PubMed |
| Vaccination Reduces Risk of Alzheimer's Disease, Parkinson's Disease and Other Neurodegenerative Disorders. | Discov Med | 2022 | 36281030 | PubTator, text mining | PubMed |
| Genetic polymorphism in BIN1 rather than APOE is associated with poor recognition memory among men without dementia. | Sci Rep | 2022 | 36280690 | PubTator, text mining | PubMed |
| Newborn Screening for Duchenne Muscular Dystrophy: First Year Results of a Population-Based Pilot. | Int J Neonatal Screen | 2022 | 36278620 | PubTator, text mining | PubMed |
| CircLRFN5 inhibits the progression of glioblastoma via PRRX2/GCH1 mediated ferroptosis. | J Exp Clin Cancer Res | 2022 | 36266731 | PubTator, text mining | PubMed |
| Stable cerebrospinal fluid neurogranin and β-site amyloid precursor protein cleaving enzyme 1 levels differentiate predementia Alzheimer's disease patients. | Brain Commun | 2022 | 36262371 | PubTator, text mining | PubMed |
| The Single-Cell Revelation of Thermogenic Adipose Tissue. | Mol Cells | 2022 | 36254709 | PubTator, text mining | PubMed |
| Lipopolysaccharide distinctively alters human microglia transcriptomes to resemble microglia from Alzheimer's disease mouse models. | Dis Model Mech | 2022 | 36254682 | PubTator, text mining | PubMed |
| Melatonin inhibits HCC progression through regulating the alternative splicing of NEMO. | Front Pharmacol | 2022 | 36225557 | PubTator, text mining | PubMed |
| Cytoskeletal dysregulation and neurodegenerative disease: Formation, monitoring, and inhibition of cofilin-actin rods. | Front Cell Neurosci | 2022 | 36212686 | PubTator, text mining | PubMed |
| Blocking LAIR1 signaling in immune cells inhibits tumor development. | Front Immunol | 2022 | 36211388 | PubTator, text mining | PubMed |
| Alzheimer's disease: insights from a network medicine perspective. | Sci Rep | 2022 | 36207441 | PubTator, text mining | PubMed |
| A scalable Bayesian functional GWAS method accounting for multivariate quantitative functional annotations with applications for studying Alzheimer disease. | HGG Adv | 2022 | 36204489 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/274/papers?page=27